Loading...

Emerging role of multikinase inhibitors for refractory thyroid cancer

Thyroid cancer incidence continues to increase, remaining the most common endocrine malignancy. The need for effective systemic therapies combined with high incidence of driver mutations and overexpression of molecular pathways make refractory thyroid cancer an ideal candidate for treatment with nov...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Perez, Cesar A, Arango, Belisario A, Velez, Michel, Raez, Luis E, Santos, Edgardo S
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3421474/
https://ncbi.nlm.nih.gov/pubmed/22904617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S24465
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!